Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors.
O’Connell N, McMahon C, Smith J, et al.
Br J Haematol 2002;116(3):632-635.
Review by Aldouri M
Massive pseudotumour resection with recombinant factor VIIa (NovoSeven) cover.
O’Connell N, Chen J, Byrne M, OShea E, Smyth H, Smith OP
Br J Haematol 2002;116(3):645-648.
Review by
Recombinant activated factor VII for adjunctive hemorrhage control in trauma.
Martinowitz U, Kenet G, Segal E, et al.
J Trauma 2001;51(3):431-438.
Review by M. Aldouri
Use of recombinant factor VIIa in hereditary bleeding disorders.
Poon MC
Curr Opin Hematol 2001;8(5):312-318.
Review by M. Aldouri
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659